Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines. | Genome Med | 2022 | 36443794 | PubTator, text mining | PubMed |
| Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. | Front Microbiol | 2022 | 36439786 | PubTator, text mining | PubMed |
| Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification. | Front Genet | 2022 | 36437951 | PubTator, text mining | PubMed |
| Human Lung Mast Cells: Therapeutic Implications in Asthma. | Int J Mol Sci | 2022 | 36430941 | PubTator, text mining | PubMed |
| Obesity-Associated Vitamin D Deficiency Correlates with Adipose Tissue DNA Hypomethylation, Inflammation, and Vascular Dysfunction. | Int J Mol Sci | 2022 | 36430854 | PubTator, text mining | PubMed |
| Mast Cells and Interleukins. | Int J Mol Sci | 2022 | 36430483 | PubTator, text mining | PubMed |
| DRPreter: Interpretable Anticancer Drug Response Prediction Using Knowledge-Guided Graph Neural Networks and Transformer. | Int J Mol Sci | 2022 | 36430395 | PubTator, text mining | PubMed |
| Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis. | Int J Mol Sci | 2022 | 36430392 | PubTator, text mining | PubMed |
| Histamine-Releasing Factor Is a Novel Alarmin Induced by House Dust Mite Allergen, Cytokines, and Cell Death. | J Immunol | 2022 | 36426937 | PubTator, text mining | PubMed |
| Protective Role of IL7A-197 A/G Heterozygosity in the Development and Severity of Colorectal Cancer in the Bulgarian Population. | Medicina (Kaunas) | 2022 | 36422171 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma. | Front Oncol | 2022 | 36419893 | PubTator, text mining | PubMed |
| Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase. | Cell Commun Signal | 2022 | 36419191 | PubTator, text mining | PubMed |
| A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis. | Sci Rep | 2022 | 36396672 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer. | Front Cell Dev Biol | 2022 | 36393842 | PubTator, text mining | PubMed |
| Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis. | Front Immunol | 2022 | 36389759 | PubTator, text mining | PubMed |
| MSC-EV therapy for bone/cartilage diseases. | Bone Rep | 2022 | 36389627 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases. | Cell Genom | 2022 | 36388766 | PubTator, text mining | PubMed |
| Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer. | Front Genet | 2022 | 36386817 | PubTator, text mining | PubMed |
| Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients. | Transl Lung Cancer Res | 2022 | 36386450 | PubTator, text mining | PubMed |
| The role of neutrophil extracellular traps in cancer progression, metastasis and therapy. | Exp Hematol Oncol | 2022 | 36384979 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=42